Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04191382
Brief Title: Phase 2 Window Study of SAR439859 (Amcenestrant) Versus Letrozole in Post-menopausal Patients With ER+, HER2- Pre-operative Post-menopausal Primary Breast Cancer (AMEERA-4)

First Submitted : December 5, 2019
First Submitted that Met QC Criteria : December 5, 2019
First Posted : December 9, 2019

Last Update Submitted that Met QC Criteria : June 24, 2021
Last Update Posted : June 29, 2021